Vycor Medical Inc
VYCO· OTC
VYCOVycor Medical Inc
Released Aug 13, 2024, during market hours
10-Q filed Aug 13, 2024, 44 days after period end · 0001493152-24-031547
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $406.28K | $482.77K | $327.92K | $491.43K |
| Net Income | -$10.04K | $68.41K | -$99.01K | -$9.37K |
| EPS Diluted | $0.00 |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| $0.00 |
| $0.00 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
